Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

436 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The adverse effect of prolonged prednisolone pretreatment in children with acute lymphoblastic leukemia.
Révész T, Kardos G, Kajtár P, Schuler D. Révész T, et al. Among authors: schuler d. Cancer. 1985 Apr 15;55(8):1637-40. doi: 10.1002/1097-0142(19850415)55:8<1637::aid-cncr2820550804>3.0.co;2-h. Cancer. 1985. PMID: 3856464
Apoptosis as a possible way of destruction of lymphoblasts after glucocorticoid treatment of children with acute lymphoblastic leukemia.
Schuler D, Szende B, Borsi JD, Marton T, Bocsi J, Magyarossy E, Koós R, Csóka M. Schuler D, et al. Pediatr Hematol Oncol. 1994 Nov-Dec;11(6):641-9. doi: 10.3109/08880019409141811. Pediatr Hematol Oncol. 1994. PMID: 7857787
Methotrexate administered by 6-h and 24-h infusion: a pharmacokinetic comparison.
Borsi JD, Schuler D, Moe PJ. Borsi JD, et al. Among authors: schuler d. Cancer Chemother Pharmacol. 1988;22(1):33-5. doi: 10.1007/BF00254177. Cancer Chemother Pharmacol. 1988. PMID: 3260832
Antibody-dependent and spontaneous cell-mediated cytotoxicity in children with acute lymphoblastic leukemia.
Láng I, Zoltán E, Révész T, Gergely P, Schuler D, Petranyi G. Láng I, et al. Among authors: schuler d. Allergol Immunopathol (Madr). 1982 Sep-Oct;10(5):341-5. Allergol Immunopathol (Madr). 1982. PMID: 6962671
Glucocorticoid-induced apoptosis and treatment sensitivity in acute lymphoblastic leukemia of children.
Csóka M, Bocsi J, Falus A, Szalai C, Klujber V, Szende B, Schuler D. Csóka M, et al. Among authors: schuler d. Pediatr Hematol Oncol. 1997 Sep-Oct;14(5):433-42. doi: 10.3109/08880019709028773. Pediatr Hematol Oncol. 1997. PMID: 9267875
[Effect of previous prednisolone therapy on the survival of children with acute lymphoid leukemia].
Révész T, Kardos G, Kajtár P, Vargha M, Kabos S, Schuler D. Révész T, et al. Among authors: schuler d. Orv Hetil. 1984 Dec 23;125(52):3155-9. Orv Hetil. 1984. PMID: 6597913 Hungarian. No abstract available.
Prognostic importance of systemic clearance of methotrexate in childhood acute lymphoblastic leukemia.
Borsi JD, Revesz T, Schuler D. Borsi JD, et al. Among authors: schuler d. Cancer Chemother Pharmacol. 1987;19(3):261-4. doi: 10.1007/BF00252984. Cancer Chemother Pharmacol. 1987. PMID: 3472677
Cytogenetic investigations on children with acute non-lymphocytic leukemia.
Oláh E, Balogh E, Szollár J, Szakmáry E, Kovács I, Schuler D, Karmazsin L. Oláh E, et al. Among authors: schuler d. Blut. 1988 Jun;56(6):249-55. doi: 10.1007/BF00320283. Blut. 1988. PMID: 3382759
Infant leukemia in Hungary.
Kardos G, Révész T, Koós R, Petróczky A, Schuler D. Kardos G, et al. Among authors: schuler d. Med Pediatr Oncol. 1982;10(2):201-7. doi: 10.1002/mpo.2950100216. Med Pediatr Oncol. 1982. PMID: 7070356
Effect of etoposide on the pharmacokinetics of methotrexate in vivo.
Paál K, Horváth J, Csáki C, Ferencz T, Schuler D, Borsi JD. Paál K, et al. Among authors: schuler d. Anticancer Drugs. 1998 Oct;9(9):765-72. doi: 10.1097/00001813-199810000-00004. Anticancer Drugs. 1998. PMID: 9840721 Clinical Trial.
436 results
Jump to page
Feedback